WCLD vs XBI
WisdomTree Cloud Computing Fund vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.45% for WCLD.
- • XBI pays a higher dividend yield (0.34%).
Side-by-side metrics
| Metric | WCLD | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.45% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $227M | $8.30B |
YTD return | -17.58% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.96 | 1.09 |
P/E ratio | 30.62 | — |
Last price | $29.73 | $133.66 |
Inception | — | — |
Issuer | WisdomTree | State Street |
WCLD top holdings
| DOCN | DigitalOcean Holdings Inc | 2.38% |
| FSLY | Fastly Inc Class A | 2.20% |
| TWLO | Twilio Inc Class A | 2.06% |
| BRZE | Braze Inc Class A | 2.01% |
| FROG | JFrog Ltd Ordinary Shares | 1.93% |
| PANW | Palo Alto Networks Inc | 1.89% |
| KVYO | Klaviyo Inc Class A common stock | 1.83% |
| NET | Cloudflare Inc | 1.82% |
| CRWD | CrowdStrike Holdings Inc Class A | 1.80% |
| DDOG | Datadog Inc Class A | 1.80% |
XBI top holdings
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
About WCLD
WCLD (WisdomTree Cloud Computing Fund) is Pure-play cloud software companies. Managed by WisdomTree, the fund carries $227M in assets under management, an expense ratio of 0.45%. Its largest holding is DigitalOcean Holdings Inc (DOCN), which represents 2.4% of the portfolio. Technology is the fund's largest sector exposure at 97.2%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.